The value proposition for point-of-care testing in healthcare: HbA1c for monitoring in diabetes management as an exemplar

References

• Roland M, Guthrie B. Quality and outcomes framework: what have we learnt? Br Med J. 2016;354:i4060.
   PubMedGoogle Scholar
• Siekman N, Hilger R. High users of healthcare: strategies to improve care, reduce costs. Cleve Clin J Med. 2018;85:25–31.
   PubMed Web of Science ®Google Scholar
• Roland M, Sibbald B, McDonald R. Care closer to home. Moving care. Health Serv J. 2007;117:suppl 6–8.
   Google Scholar
• Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med. 2009;361:109–112.
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Robert G, Macfarlane F, et al. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82:581–629.
   PubMed Web of Science ®Google Scholar
• NHS Institute for Innovation and Improvement. Organisational and Behavioural Barriers to Medical Technology Adoption. Available from http://www.institute.nhs.uk/images/ResearchAndEvaluationReports/OBB_MTA.pdf [last accessed 20 February 2019].
   Google Scholar
• Ivanov A. Barriers to the introduction of new medical diagnostic tests. Lab Med. 2013;44:e132–e136.
   Google Scholar
• Jabbal J, Lewis M. Approaches to better value in the NHS, Improving quality and cost. Available from https://www.kingsfund.org.uk/publications/approaches-better-value [last accessed 20 February 2019].
   Google Scholar
• Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–2481.
   PubMed Web of Science ®Google Scholar
• Donabedian A. An introduction to quality assurance in health care. Oxford (UK): Oxford University Press; 2003.
   Google Scholar
• Dixon-Woods M, Amalberti R, Goodman S, et al. Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new. BMJ Qual Saf. 2011;20:i47–51.
   PubMed Web of Science ®Google Scholar
• Price CP, St John A. Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta. 2014;427:71–78.
   PubMed Web of Science ®Google Scholar
• Zhi M, Ding EL, Theisen-Toupal J, et al. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS ONE. 2013;8:e78962.
   PubMed Web of Science ®Google Scholar
• Callen J, Georgiou A, Li J, et al. The safety implications of missed test results for hospitalised patients: a systematic review. BMJ Qual Saf. 2011;20:194–199.
   PubMed Web of Science ®Google Scholar
• Porter ME, Teisberg EO. How physicians can change the future of health care. JAMA. 2007;297:1103–1111.
   PubMed Web of Science ®Google Scholar
• Leviton LC, Melichar L. Balancing stakeholder needs in the evaluation of healthcare quality improvement. BMJ Qual Saf. 2016;25:803–807.
   PubMed Web of Science ®Google Scholar
• Kyratsis Y, Ahmad R, Holmes A. Technology adoption and implementation in organisations: comparative case studies of 12 English NHS Trusts. BMJ Open. 2012;2:e000872.
   PubMed Web of Science ®Google Scholar
• Price CP, St John A. Anatomy of a value proposition for laboratory medicine. Clin Chim Acta. 2014;436:104–111.
   PubMed Web of Science ®Google Scholar
• Barnes C, Blake H, Pinder D. Creating and delivering your value proposition: managing customer experience for profit. London (UK): Kogan Page; 2009.
   Google Scholar
• Christensen CM, Grossman JH, Hwang J. The Innovator’s Prescription. A disruptive solution for health care. New York (NY): McGraw Hill; 2009.
   Google Scholar
• Price CP, St John A, Kricka LJ, editors. Third edition. Point-of-care testing. Needs, opportunity and innovation. Washington (DC): AACC Press; 2010.
   Google Scholar
• Laurence CO, Gialamas A, Bubner T, Point of Care Testing in General Practice Trial Management Group, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60:e98–104.
   PubMed Web of Science ®Google Scholar
• Al-Ansary L, Farmer A, Hirst J, et al. Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis. Clin Chem. 2011;57:568–576.
   PubMed Web of Science ®Google Scholar
• Schnell O, Crocker JB, Weng J. Impact of HbA1c testing at point of care on diabetes management. J Diabetes Sci Technol. 2017;11:611–617.
   PubMedGoogle Scholar
• Chadee A, Blackhouse G, Goeree R. Point-of-care hemoglobin A1c testing: a budget impact analysis. Ontario Health Technol Assess Ser. 2014;14:1–23.
   PubMedGoogle Scholar
• Patzer KH, Ardjomand P, Göhring K, et al. Implementation of HbA1c point of care testing in 3 German medical practices: impact on workflow and physician, staff, and patient satisfaction. J Diabetes Sci Technol. 2018;12:687–694.
   PubMedGoogle Scholar
• Shephard MD, Mazzachi BC, Shephard AK, et al. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health. 2005;5:371.
   PubMedGoogle Scholar
• Spaeth BA, Shephard MDS, Schatz S. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural Remote Health. 2014;14:2849.
   PubMed Web of Science ®Google Scholar
• Motta LA, Shephard MDS, Brink J, et al. Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Prim Care Diabetes. 2017;11:248–253.
   PubMed Web of Science ®Google Scholar
• Grieve R, Beech R, Vincent J, et al. Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Assess. 1999;3:1–74.
   PubMedGoogle Scholar
• Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999;22:1785–1789.
   PubMed Web of Science ®Google Scholar
• Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22:1415–1421.
   PubMed Web of Science ®Google Scholar
• Ferenczi A, Reddy K, Lorber DL. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract. 2001;7:85–88.
   PubMedGoogle Scholar
• Miller CD, Barnes CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158–1163.
   PubMed Web of Science ®Google Scholar
• Brown JB, Harris SB, Webster-Bogaert S, et al. Point-of-care testing in diabetes management: what role does it play? Diabetes Spectrum. 2004;17:244–248.
   Google Scholar
• Khunti K, Stone MA, Burden AC, et al. Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. Br J Gen Pract. 2006;56:511–517.
   PubMed Web of Science ®Google Scholar
• Kennedy L, Herman WH, Strange P, et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care. 2006;29:1–8.
   PubMed Web of Science ®Google Scholar
• Petersen JR, Finley JB, Okorodudu AO, et al. Effect of point-of-care on maintenance of glycemic control as measured by A1C. Diabetes Care. 2007;30:713–715.
   PubMed Web of Science ®Google Scholar
• Rust G, Gailor M, Daniels E, et al. Point of care testing to improve glycemic control. Int J Health Care Qual Assur. 2008;21:325–335.
   PubMedGoogle Scholar
• Bubner TK, Laurence CO, Gialamas A, et al. Effectiveness of point of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Med J Aust. 2009;190:624–626.
   PubMed Web of Science ®Google Scholar
• Agus MS, Alexander JL, Wolfsdorf JI. Utility of immediate hemoglobin A1c in children with type I diabetes mellitus. Pediatr Diabetes. 2010;11:450–454.
   PubMed Web of Science ®Google Scholar
• Egbunike V, Gerard S. The impact of point-of-care A1C testing on provider compliance and A1C levels in a primary setting. Diabetes Educ. 2013;39:66–73.
   PubMed Web of Science ®Google Scholar
• Crocker JB, Lee-Lewandrowski E, Lewandrowski N, et al. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014;142:640–646.
   PubMed Web of Science ®Google Scholar
• Laurence CO, Moss JR, Briggs NE, et al. The cost effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial. BMC Health Serv Res. 2010;10:165.
   PubMed Web of Science ®Google Scholar
• Stone MA, Burden AC, Burden M, et al. Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabetic Med. 2007;24:792–795.
   PubMed Web of Science ®Google Scholar
• Crocker B, Lewandrowski EL, Lewandrowski N, et al. Patient satisfaction with point-of-care laboratory testing: report of a quality improvement program in an ambulatory practice of an academic medical center. Clin Chim Acta. 2013;424:8–11.
   PubMed Web of Science ®Google Scholar
• Price CP, Smith I, Van den Bruel A. Improving the quality of point-of-care testing. Fam Pract. 2018;35:358–364.
   PubMed Web of Science ®Google Scholar
• Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82:131–138.
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Fahy N, Shaw S. The bright elusive butterfly of value in health technology development. Int J Health Policy Manag. 2017;6:1–5.
   Google Scholar
• Heitmueller A, Bull A, Oh S. Looking in the wrong places: why traditional solutions to the diffusion of innovation will not work. BMJ Innov. 2016;2:41–47.
   Google Scholar